BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BCL9, LGS, 607, ENSG00000116128, MGC131591 AND Treatment
32 results:

  • 1. Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomes.
    Liu H; Zou H; Shan D; Liu W; Huang W; Sui W; Deng S; Wang T; Lv R; Fu M; Xu Y; Yi S; An G; Zhao Y; Qiu L; Zou D
    Cancer Med; 2024 Jan; 13(2):e6965. PubMed ID: 38348996
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
    Burns EA; Wilson JJ; Mathur S; Kieser R; Gong Z; Hu CA; Tang CA; Petkova J; Yuen C; Mai H; Shah S; Rice L; Ganguly S; Pingali SR
    Ann Hematol; 2023 Oct; 102(10):2753-2763. PubMed ID: 37422592
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Structural basis of the interaction between bcl9-Pygo and LDB-SSBP complexes in assembling the Wnt enhanceosome.
    Wang H; Bienz M; Yan XX; Xu W
    Nat Commun; 2023 Jun; 14(1):3702. PubMed ID: 37349336
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
    Gill H; Raghupathy R; Lee CYY; Yung Y; Chu HT; Ni MY; Xiao X; Flores FP; Yim R; Lee P; Chin L; Li VWK; Au L; Au WY; Ma ESK; Mohan D; Kumana CR; Kwong YL
    BMC Cancer; 2023 Feb; 23(1):141. PubMed ID: 36765318
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discovery of Novel 3-Phenylpiperidine Derivatives Targeting the β-Catenin/B-Cell lymphoma 9 Interaction as a Single Agent and in Combination with the Anti-PD-1 Antibody for the treatment of Colorectal Cancer.
    Zhang H; Liu C; Chen Q; Shen LA; Xiao W; Li J; Wang Y; Zhu D; Zhang Q; Li J
    J Med Chem; 2023 Jan; 66(2):1349-1379. PubMed ID: 36630177
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The cost-effectiveness of brigatinib in adult patients with ALK inhibitor-naive ALK-positive non-small cell lung cancer from a US perspective.
    Cranmer H; Kearns I; Young M; Humphries MJ; Trueman D
    J Manag Care Spec Pharm; 2022 Sep; 28(9):970-979. PubMed ID: 36001099
    [No Abstract]    [Full Text] [Related]  

  • 7. Exosomal AFAP1-AS1 binds to microRNA-15a-5p to promote the proliferation, migration, and invasion of ectopic endometrial stromal cells in endometriosis.
    Wang X; Zhang M; Jiang L; Fang X; Zhang T
    Reprod Biol Endocrinol; 2022 May; 20(1):77. PubMed ID: 35513844
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptake.
    Georgi TW; Zieschank A; Kornrumpf K; Kurch L; Sabri O; Körholz D; Mauz-Körholz C; Kluge R; Posch S
    PLoS One; 2022; 17(4):e0267275. PubMed ID: 35436321
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. bcl9 regulates CD226 and CD96 checkpoints in CD8
    Feng M; Wu Z; Zhou Y; Wei Z; Tian E; Mei S; Zhu Y; Liu C; He F; Li H; Xie C; Jin J; Dong J; Yang D; Yu K; Qian J; Lambrechts D; Wang MW; Zhu D
    Signal Transduct Target Ther; 2021 Aug; 6(1):313. PubMed ID: 34417435
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficient Prophylactic Management of HBV Reactivation by an Information Technology Encoding System: Results of a 6-year Prospective Cohort Study.
    Notsumata K; Nomura Y; Tanaka A; Nomura Y; Ueda T; Sanada T; Watanabe H; Toya D
    Intern Med; 2020; 59(20):2457-2464. PubMed ID: 33055468
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Outcomes of treatment for HIV-Infected lymphoma Patients: A National Cancer Database (NCDB) Analysis.
    Jayakrishnan TT; Bakalov V; Samhouri Y; Wegner RE; Sadashiv S
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e864-e870. PubMed ID: 32665185
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
    Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
    Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. bcl9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins.
    Jiang M; Kang Y; Sewastianik T; Wang J; Tanton H; Alder K; Dennis P; Xin Y; Wang Z; Liu R; Zhang M; Huang Y; Loda M; Srivastava A; Chen R; Liu M; Carrasco RD
    Nat Commun; 2020 Jan; 11(1):19. PubMed ID: 31911584
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular lymphoma: Long-Term Results of the PRIMA Study.
    Bachy E; Seymour JF; Feugier P; Offner F; López-Guillermo A; Belada D; Xerri L; Catalano JV; Brice P; Lemonnier F; Martin A; Casasnovas O; Pedersen LM; Dorvaux V; Simpson D; Leppa S; Gabarre J; da Silva MG; Glaisner S; Ysebaert L; Vekhoff A; Intragumtornchai T; Le Gouill S; Lister A; Estell JA; Milone G; Sonet A; Farhi J; Zeuner H; Tilly H; Salles G
    J Clin Oncol; 2019 Nov; 37(31):2815-2824. PubMed ID: 31339826
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
    Hangai M; Urayama KY; Tanaka J; Kato K; Nishiwaki S; Koh K; Noguchi M; Kato K; Yoshida N; Sato M; Goto H; Yuza Y; Hashii Y; Atsuta Y; Mizuta S; Kato M
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1597-1602. PubMed ID: 31002992
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical and molecular characteristics of
    Ohki K; Kiyokawa N; Saito Y; Hirabayashi S; Nakabayashi K; Ichikawa H; Momozawa Y; Okamura K; Yoshimi A; Ogata-Kawata H; Sakamoto H; Kato M; Fukushima K; Hasegawa D; Fukushima H; Imai M; Kajiwara R; Koike T; Komori I; Matsui A; Mori M; Moriwaki K; Noguchi Y; Park MJ; Ueda T; Yamamoto S; Matsuda K; Yoshida T; Matsumoto K; Hata K; Kubo M; Matsubara Y; Takahashi H; Fukushima T; Hayashi Y; Koh K; Manabe A; Ohara A;
    Haematologica; 2019 Jan; 104(1):128-137. PubMed ID: 30171027
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Outcome of patients with early-stage follicular lymphoma staged with
    Ng SP; Khor R; Bressel M; MacManus M; Seymour JF; Hicks RJ; Wirth A
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):80-86. PubMed ID: 30083824
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. bcl9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway.
    Li B; Cai S; Zhao Y; He Q; Yu X; Cheng L; Zhang Y; Hu X; Ke M; Chen S; Zou M
    Oncotarget; 2016 Dec; 7(49):81026-81048. PubMed ID: 27835587
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.
    Gu Z; Churchman M; Roberts K; Li Y; Liu Y; Harvey RC; McCastlain K; Reshmi SC; Payne-Turner D; Iacobucci I; Shao Y; Chen IM; Valentine M; Pei D; Mungall KL; Mungall AJ; Ma Y; Moore R; Marra M; Stonerock E; Gastier-Foster JM; Devidas M; Dai Y; Wood B; Borowitz M; Larsen EE; Maloney K; Mattano LA; Angiolillo A; Salzer WL; Burke MJ; Gianni F; Spinelli O; Radich JP; Minden MD; Moorman AV; Patel B; Fielding AK; Rowe JM; Luger SM; Bhatia R; Aldoss I; Forman SJ; Kohlschmidt J; Mrózek K; Marcucci G; Bloomfield CD; Stock W; Kornblau S; Kantarjian HM; Konopleva M; Paietta E; Willman CL; Loh ML; Hunger SP; Mullighan CG
    Nat Commun; 2016 Nov; 7():13331. PubMed ID: 27824051
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.